A NanoLuc luciferase-based assay enabling the real-time analysis of protein secretion and injection by bacterial type III secretion systems.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Westerhausen, SibelNowak, Melanie
Torres-Vargas, Claudia E
Bilitewski, Ursula
Bohn, Erwin
Grin, Iwan
Wagner, Samuel
Issue Date
2020-02-18
Metadata
Show full item recordAbstract
The elucidation of the molecular mechanisms of secretion through bacterial protein secretion systems is impeded by a shortage of assays to quantitatively assess secretion kinetics. Also the analysis of the biological role of these secretion systems as well as the identification of inhibitors targeting these systems would greatly benefit from the availability of a simple, quick and quantitative assay to monitor principle secretion and injection into host cells. Here, we present a versatile solution to this need, utilizing the small and very bright NanoLuc luciferase to assess the function of the type III secretion system encoded by Salmonella pathogenicity island 1. Type III secretion substrate-NanoLuc fusions are readily secreted into the culture supernatant, where they can be quantified by luminometry after removal of bacteria. The NanoLuc-based secretion assay features a very high signal-to-noise ratio and sensitivity down to the nanolitre scale. The assay enables monitoring of secretion kinetics and is adaptable to a high throughput screening format in 384-well microplates. We further developed a split NanoLuc-based assay that enables the real-time monitoring of type III secretion-dependent injection of effector-HiBiT fusions into host cells stably expressing the complementing NanoLuc-LgBiT.Citation
Mol Microbiol. 2020 Feb 18. doi: 10.1111/mmi.14490.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
WileyJournal
Molecular microbiologyPubMed ID
32068313Type
ArticleLanguage
enEISSN
1365-2958ae974a485f413a2113503eed53cd6c53
10.1111/mmi.14490
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Analysis of SPI-1 Dependent Type III Secretion and Injection Using a NanoLuc Luciferase-Based Assay.
- Authors: Pais SV, Westerhausen S, Bohn E, Wagner S
- Issue date: 2022
- High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway.
- Authors: Ernst NH, Reeves AZ, Ramseyer JE, Lesser CF
- Issue date: 2018 Jun 19
- Development of a rapid and quantitative method for the analysis of viral entry and release using a NanoLuc luciferase complementation assay.
- Authors: Sasaki M, Anindita PD, Phongphaew W, Carr M, Kobayashi S, Orba Y, Sawa H
- Issue date: 2018 Jan 2
- In Vitro Reconstitution of Functional Type III Protein Export and Insights into Flagellar Assembly.
- Authors: Terashima H, Kawamoto A, Tatsumi C, Namba K, Minamino T, Imada K
- Issue date: 2018 Jun 26
- An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle.
- Authors: De Niz M, Stanway RR, Wacker R, Keller D, Heussler VT
- Issue date: 2016 Apr 21